Market Pulse: Sentiment swung wildly as Bitcoin shed its $63.5K support and traders piled on a near-certainty bet that Micron will outpace earnings. Uncertainty from legal blows in Washington and drones buzzing the Strait of Hormuz left desks split between risk-on and sheltering.
Key Movers: Read how “Bitcoin Loses $63,500 Support As Heatmaps Show Liquidity Building Above Price” and “Polymarket prices 96% chance Micron beats earnings Wednesday,” then note the churn in cruise names in “Carnival Plunges 6% While Royal Caribbean and Norwegian Tread Water: Here’s Why.”
Macro & Politics: A federal court knocked down Trump’s Right to Try claim, reminding us regs still bite, while AI investment frenzy drowns out Iran jitters and Fed hold-rate mumblings.
What’s Next: Eyes on Thursday’s Micron report and any Fed commentary before the opening bell.
Market Commentary
Here’s what most folks are overlooking: liquidity building above spot in Bitcoin, highlighted in “Bitcoin Loses $63,500 Support As Heatmaps Show Liquidity Building Above Price” (Bitcoinist), is a ticking time bomb for momentum players. Everyone’s fixated on a dip buy—yet those heatmaps spell a potential cascade if sellers keep stacking up.
Now link that to the regulatory reminder from “No Evidence for Trump’s Right to Try Claim” (FactCheck.org) and the MacroGenics milestone in “MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval” (GlobeNewswire). Both stories prove it: whether it’s crypto or biotech, government and guardrails can hijack the wildest rallies.
Action time: trim exposure in crowded trades—tighten stops on Bitcoin and memory-chip bets—and scout out under-the-radar biotech names with strong data backstops. The market’s about to separate those who chased hype from those who bet on substance.
📈 Breaking Financial News
Polymarket prices 96% chance Micron beats earnings Wednesday
Micron's potential earnings beat highlights the critical role of AI infrastructure demand in shaping semiconductor market dynamics. The post Polymarket prices 96% chance Micron beats earnings Wednesday appeared first on Crypto Briefing.
AI Momentum Outweighs Iran Risks and Fed Concerns, Says Chief Economist
Stephanie Roth, chief economist at Wolfe Research, argued on a CNBC Morning Call that the AI capex cycle has runway, geopolitical risk is being absorbed by t…
Bitcoin Loses $63,500 Support As Heatmaps Show Liquidity Building Above Price
Bitcoin has lost a support level that traders had been watching closely, with The Martini Guy warning that buyers failed to defend the $63,500 area while l
Innovation or Not – Midjourney Medical and the Illusion of Frictionless Health
by Braden Kelley and Art Inteligencia For years, the technology world has watched Midjourney dominate the digital canvas, turning text prompts into breathtaking generative art. But in an unexpected, high-stakes pivot, the self-funded AI research lab is shifti…
SpaceX seeing some interest from short sellers, but many still afraid to bet against Musk
About 40 million SpaceX shares are sold short, roughly 5% to 7% of the shares that are publicly available to trade, according to an estimate by S3 Partners.
The Comeback of the Century: Wall Street Wrote Him Off…
But Elon's $3 Trillion Comeback Could Begin Soon Elon Musk was declared washed up and finished. But any day now, he could unveil a new technology that outshines Tesla, SpaceX, even PayPal… a breakthrough big enough to solve America's toughest problem, make President Trump a hero to the Western World… and spark a $3 trillion boom. Early investors could see massive gains. Details here.
🔍 Market Analysis & Insights
Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
The acute kidney injury clinical trial analysis report delivers important insights into ongoing research of 25+ pipeline acute kidney injury drugs, clinical strategies, upcoming therapeutics, and commercial analysis. The acute kidney injury clinical trial ana…
Carnival Plunges 6% While Royal Caribbean and Norwegian Tread Water: Here’s Why
Carnival (NYSE:CCL) stock is under pressure today, falling 6% to $28.41 as investors react to its latest quarterly earnings report. The move stands out again…
This Startup Says It Saves Medicare More Than $2 Million A Week
Cadence reached a $1.2 billion valuation by using AI to track seniors’ chronic health conditions and improve their care.
MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
ROCKVILLE, MD, June 22, 2026 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that it will receive a $24.…
No Evidence for Trump’s Right to Try Claim
As he has done for years, President Donald Trump claims – without evidence – that the federal Right to Try law he signed in 2018 has “saved thousands of lives.” Researchers who have long studied access to investigational drugs say the president is greatly exa…
How To Profit From Starlink's $180 Billion IPO Jackpot?
Have you heard the big news? Elon Musk's company Starlink is preparing to announce their IPO as soon as March 26th! According to Quartz, “Elon Musk's Starlink IPO may lift off any day now” And for the first time ever, you have the rare chance to see how to profit BEFORE the IPO takes place. Click here now for the time-sensitive details.
💰 Investment Opportunities
Netflix Stock Drops Near Multi-Month Lows as Failed Roku, Warner Bros. Bids Weigh on Shares
Netflix shares dropped 4.59% amid investor concerns over failed acquisitions and margin pressures, with the stock nearing its 52-week low. Analysts remain cautious despite strong first-quarter results.
Solana price reclaims $74, nearing a major breakout zone
Solana (SOL) is stuck between $72 support and $76 resistance. Solana’s price action shows a tight range with possible short-term rejection risk. $90 remains the key breakout level for a stronger bullish move. Solana has moved back above the $74 level after a …
Knoa Pharma to Present Pipeline Assets at BIO International Convention 2026
The Company will showcase its pipeline and invite conversations with potential partners at the biotechnology industry's premier global event, June 22–25. STAMFORD, Conn., June 22, 2026 /PRNewswire/ — Knoa Pharma LLC (“Knoa Pharma”), a public health-focused p…
Is EchoStar Corporation (SATS) A Good Stock To Buy Now?
Is SATS a good stock to buy? We came across a bullish thesis on EchoStar Corporation on r/ValueInvesting by OddAbbreviations7835. In this article, we will su…
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
CRL Cites Deficiencies at Third-Party Manufacturing Facility No Efficacy or Clinical Safety Deficiencies Identified SEATTLE and VANCOUVER, British…
Bitcoin In Serious Danger of Disappearing From Exchanges…
This could be the biggest “supply shock” in financial history! Bitcoin on exchanges is being bought up faster than miners can mine it. The smart money like BlackRock, Goldman Sachs, and MicroStrategy are doubling, tripling, quadrupling down. And they're doing everything they can to buy up ONE altcoin before prices blast-off like a Space X rocket. Discover the ONE altcoin smart money is buying up before Bitcoin's supply shock.